Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire ...
NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger ...
Morgan Stanley provided investor feedback on Clearwater Analytics (CWAN) following upgrade of the software solution ...
In a report released yesterday, Michael Infante from Morgan Stanley maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research ...
NYSE:ENFN) Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...
BOISE, Idaho - Clearwater Analytics (NYSE: CWAN), known for its investment management and analytics solutions, has been ...
James S. Cox, the Chief Financial Officer of Clearwater Analytics Holdings, Inc. (NYSE:CWAN), has recently disclosed the sale ...
12d
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) , relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of ...
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.
They emphasized the significance of integrating Enfusion's technology, which is expected to enhance Clearwater's offerings and potentially drive future growth. Clearwater Analytics specializes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback